SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ueland T.)
 

Sökning: WFRF:(Ueland T.) > Legumain in Acute C...

  • Gregersen, IdaOslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway. (författare)

Legumain in Acute Coronary Syndromes : A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • WILEY,2020
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-421273
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-421273URI
  • https://doi.org/10.1161/JAHA.120.016360DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND: The cysteine protease legumain is increased in patients with atherosclerosis, but its causal role in atherogenesis and cardiovascular disease is still unclear. The aim of the study was to investigate the association of legumain with clinical outcome in a large cohort of patients with acute coronary syndrome. METHODS AND RESULTS : Serum levels of legumain were analyzed in 4883 patients with acute coronary syndrome from a substudy of the PLATO (Platelet Inhibition and Patient Outcomes) trial. Levels were analyzed at admission and after 1 month follow-up. Associations between legumain and a composite of cardiovascular death, spontaneous myocardial infarction or stroke, and its individual components were assessed by multivariable Cox regression analyses. At baseline, a 50% increase in legumain level was associated with a hazard ratio (HR) of 1.13 (95% CI, 1.04-1.21),P=0.0018, for the primary composite end point, adjusted for randomized treatment. The association remained significant after adjustment for important clinical and demographic variables (HR, 1.10; 95% CI, 1.02-1.19;P=0.013) but not in the fully adjusted model. Legumain levels at 1 month were not associated with the composite end point but were negatively associated with stroke (HR, 0.62; 95% CI, 0.44-0.88;P=0.0069), including in the fully adjusted model (HR, 0.57; 95% CI, 0.37-0.88;P=0.0114). CONCLUSIONS: Baseline legumain was associated with the primary outcome in patients with acute coronary syndrome, but not in the fully adjusted model. The association between high levels of legumain at 1 month and decreased occurrence of stroke could be of interest from a mechanistic point of view, illustrating the potential dual role of legumain during atherogenesis and acute coronary syndrome. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00391872.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Michelsen, Annika E.Oslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway. (författare)
  • Lunde, Ngoc Nguyen (författare)
  • Åkerblom, Axel,1977-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden(Swepub:uu)axeak985 (författare)
  • Ghukasyan, TatevikUppsala universitet,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)tatgh570 (författare)
  • Skjelland, MonaOslo Univ Hosp, Rikshosp, Dept Neurol, Oslo, Norway. (författare)
  • Skagen, Karolina RyengOslo Univ Hosp, Rikshosp, Dept Neurol, Oslo, Norway. (författare)
  • Becker, Richard C.Acad Hlth Ctr, Div Cardiovasc Hlth & Dis, Heart Lung & Vasc Inst, Cincinnati, OH USA. (författare)
  • Lindbäck, JohanUppsala universitet,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)jolin255 (författare)
  • Himmelmann, AndersAstraZeneca Res & Dev, Gothenburg, Sweden. (författare)
  • Solberg, RigmorUniv Oslo, Sect Pharmacol & Pharmaceut Biosci, Dept Pharm, Oslo, Norway. (författare)
  • Johansen, Harald T.Univ Oslo, Sect Pharmacol & Pharmaceut Biosci, Dept Pharm, Oslo, Norway. (författare)
  • James, Stefan,1964-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden.;Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden.(Swepub:uu)stjam367 (författare)
  • Siegbahn, Agneta,1947-Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden.(Swepub:uu)agsie424 (författare)
  • Storey, Robert F.Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England. (författare)
  • Kontny, FredericStavanger Univ Hosp, Dept Cardiol, Stavanger, Norway.;Drammen Heart Ctr, Drammen, Norway. (författare)
  • Aukrust, PalOslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.;Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway.;Arctic Univ Tromso, Fac Hlth Sci, KG Jebsen TREC, Tromso, Norway. (författare)
  • Ueland, ThorOslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.;Arctic Univ Tromso, Fac Hlth Sci, KG Jebsen TREC, Tromso, Norway. (författare)
  • Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall (författare)
  • Halvorsen, BenteOslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway. (författare)
  • Oslo Univ Hosp, Res Inst Internal Med, Rikshosp, Sognsvannveien 72, N-0372 Oslo, Norway.;Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.Uppsala kliniska forskningscentrum (UCR) (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of the American Heart Association: WILEY9:172047-9980

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy